NKG2-D Antibodies

Santa Cruz Biotechnology offers a broad range of NKG2-D monoclonal antibodies for immunology and cancer biology research. NKG2-D monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). NKG2-D is a crucial activating receptor found on natural killer (NK) cells and certain T cells, playing a significant role in the immune response against tumors and virally infected cells. By recognizing stress-induced ligands on target cells, NKG2-D contributes to the elimination of transformed or infected cells, making it an important focus in cancer immunotherapy research. Understanding the function and regulation of NKG2-D is vital for developing strategies to enhance anti-tumor immunity. Researchers can utilize NKG2-D monoclonal antibodies to explore receptor expression patterns across different cell types and tissues. The high specificity of NKG2-D monoclonal antibodies enables precise detection and analysis of receptor-ligand interactions. Santa Cruz Biotechnology monoclonal antibodies for NKG2-D support researchers worldwide in advancing our understanding of immune system regulation and cancer biology.